These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17349706)

  • 1. The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate.
    Steggerda MJ; Moonen LM; van der Poel HG; Schneider CJ
    Radiother Oncol; 2007 Apr; 83(1):11-7. PubMed ID: 17349706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors.
    Steggerda MJ; van der Poel HG; Moonen LM
    Radiother Oncol; 2008 Jul; 88(1):108-14. PubMed ID: 18039548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density.
    Thomas CW; Kruk A; McGahan CE; Spadinger I; Morris WJ
    Radiother Oncol; 2007 Apr; 83(1):18-24. PubMed ID: 17368844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
    Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
    Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
    McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan.
    Waterman FM; Dicker AP
    Med Phys; 2000 Mar; 27(3):448-51. PubMed ID: 10757596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy in patients with small prostate glands.
    Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
    Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the Day 0 CT-scan predict the post-implant scanning? Results from 136 prostate cancer patients.
    Cattani F; Vavassori A; Comi S; Gherardi F; Russo S; Orecchia R; Jereczek-Fossa BA
    Phys Med; 2017 Aug; 40():66-71. PubMed ID: 28743617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
    Miksys N; Vigneault E; Martin AG; Beaulieu L; Thomson RM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):606-615. PubMed ID: 28126308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.
    Hathout L; Folkert MR; Kollmeier MA; Yamada Y; Cohen GN; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):312-9. PubMed ID: 25304791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
    Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
    Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.
    Nasser NJ; Cohen GN; Dauer LT; Zelefsky MJ
    Brachytherapy; 2016; 15(4):420-425. PubMed ID: 27180125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.